May MIMS update

A look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Product Nelarabine (Nelarabine‑Reach) is a pro‑drug of the deoxyguanosine analogue ara‑G. Nelarabine is rapidly demethylated by adenosine deaminase (ADA) to ara‑G and then phosphorylated intracellularly by deoxyguanosine kinase and deoxycytidine kinase to its 5'‑monophosphate metabolite. The

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Budget a fail for NAPSA
Next Hospital pharmacists respond to misleading titles query